Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Granulation tissue formation is a critical phase of the wound healing process, characterized by the proliferation of fibroblasts, keratinocytes, endothelial cells, and the development of new capillaries within an extracellular matrix primarily composed of type III collagen[1][2][4]. This phase facilitates wound closure by generating a vascularized and cellular scaffold that fills tissue defects, supports re-epithelialization, and is eventually remodeled into scar tissue[1][2]. The process is regulated by growth factors such as TGF-β, VEGF, and PDGF, and can be disrupted by infection, foreign material, or systemic disease, leading to either chronic wounds or hypertrophic scarring[2][3][4]. As a pathway, it is not a single molecular drug target, but a dynamic interplay of several cell types and signaling molecules[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granulation tissue formation pathway.